Partnership Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$840K Sell
29,452
-162
-0.5% -$4.31K 0.6% 33
2026
Q2
$713K Hold
29,614
– – 0.48% 34
2026
Q1
$832K Buy
29,614
+162
+0.6% +$4.31K 0.63% 33
2025
Q4
$733K Hold
29,452
– – 0.53% 35
2025
Q3
$750K Hold
29,452
– – 0.58% 33
2025
Q2
$714K Hold
29,452
– – 0.58% 37
2025
Q1
$746K Hold
29,452
– – 0.63% 35
2024
Q4
$781K Hold
29,452
– – 0.65% 37
2024
Q3
$852K Hold
29,452
– – 0.6% 35
2024
Q2
$824K Hold
29,452
– – 0.61% 42
2024
Q1
$817K Hold
29,452
– – 0.57% 50
2023
Q4
$798K Buy
+29,452
New +$890K 0.6% 44

Other funds holding PFE

Partnership Wealth Management's PFE Position: Q3 2026 in Review

Partnership Wealth Management reduced its Pfizer (PFE) stake by 0.55% in Q3 2026, selling an estimated $4.31K and leaving 29,452 shares worth $840K. The position accounts for 0.6% of the portfolio, ranked #33.

Partnership Wealth Management first reported a position in PFE in Q4 2023 and has held it in 12 quarters since. The position peaked at $852K in Q3 2024. 156 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Partnership Wealth Management held 29,452 shares of Pfizer worth $840K as of Q3 2026.
  • Partnership Wealth Management sold 162 Pfizer shares in Q3 2026, an estimated $4.31K.
  • Pfizer made up 0.6% of Partnership Wealth Management's portfolio in Q3 2026, its #33 holding.
  • Partnership Wealth Management first reported a position in Pfizer in Q4 2023 and has held it in 12 quarters since.
  • Partnership Wealth Management's Pfizer position peaked at $852K in Q3 2024.
  • 156 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Partnership Wealth Management's 13F filing for Q3 2026, filed 5 Oct 2026.